Related references
Note: Only part of the references are listed.Reduction of Dialysate Calcium Level Reduces Progression of Coronary Artery Calcification and Improves Low Bone Turnover in Patients on Hemodialysis
Ercan Ok et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0mEq/L to 2.75mEq/L
Shunsuke Yamada et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2016)
Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients
Emilie Merle et al.
KIDNEY INTERNATIONAL (2016)
Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells
Ken-ichiro Tanaka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Impact of Dialysate Calcium Concentration on Clinical Outcomes in Incident Hemodialysis Patients
Hyung Wook Kim et al.
MEDICINE (2015)
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)
Ikuto Masakane et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2015)
Advanced Glycation End Product 3 (AGE3) Suppresses the Mineralization of Mouse Stromal ST2 Cells and Human Mesenchymal Stem Cells by Increasing TGF-β Expression and Secretion
Masakazu Notsu et al.
ENDOCRINOLOGY (2014)
Mineral Metabolism Markers Are Associated with Myocardial Infarction and Hemorrhagic Stroke but Not Ischemic Stroke in Hemodialysis Patients: A Longitudinal Study
Miho Tagawa et al.
PLOS ONE (2014)
Higher dialysate calcium is not associated with mortality in hemodialysis patients: Results from the French ARNOS study
Guillaume Jean et al.
NEPHROLOGIE & THERAPEUTIQUE (2013)
Biological impact of targeted dialysate calcium changes in haemodialysis patients: the key role of parathyroid hormone
Guillaume Jean et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Clinical Practice Guideline for the Management of Chronic Kidney Disease-Mineral and Bone Disorder
Masafumi Fukagawa et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2013)
Effect of Dialysate Calcium Concentrations on Parathyroid Hormone and Calcium Balance During a Single Dialysis Session Using Bicarbonate Hemodialysis: A Crossover Clinical Trial
Carlo Basile et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Advanced Glycation End Products (AGEs), but not High Glucose, Inhibit the Osteoblastic Differentiation of Mouse Stromal ST2 Cells Through the Suppression of Osterix Expression, and Inhibit Cell Growth and Increasing Cell Apoptosis
Kyoko Okazaki et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
Secular Trends in Cardiovascular Mortality Rates of Patients Receiving Dialysis Compared With the General Population
Matthew A. Roberts et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Mineral Metabolism Management in Hemodialysis Patients with Secondary Hyperparathyroidism in Japan: Baseline Data from the MBD-5D
Masafumi Fukagawa et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population
Juergen Floege et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Effects of Lowering Dialysate Calcium Concentrations on Arterial Stiffness in Patients Undergoing Hemodialysis
Jwa-Kyung Kim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2011)
Effects of acute variation of dialysate calcium concentrations on arterial stiffness and aortic pressure waveform
Amelie LeBeouf et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Effects of serum calcium, phosphorous, and intact parathyroid hormone levels on survival in chronic hemodialysis patients in Japan
Shigeru Nakai et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2008)
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients
K. Kalantar-Zadeh et al.
KIDNEY INTERNATIONAL (2006)
Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: The USRDS waves 1, 3, and 4 study
Y Slinin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study
EW Young et al.
KIDNEY INTERNATIONAL (2005)
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
GA Block et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)
HC Rayner et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus
M Inaba et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)